110139-15-6

Basic information

• Product Name: N-(8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide
• Synonyms: N-(8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide
• CAS NO: 110139-15-6
• Molecular Formula: C₁₂H₁₃NO₂
• Molecular Weight: 203.23712
• Mol File: 110139-15-6.mol
• Article Data: 14

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: N-(8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide(CAS DataBase Reference)
• NIST Chemistry Reference: N-(8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide(110139-15-6)
• EPA Substance Registry System: N-(8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide(110139-15-6)

Safety Data

• Hazardous Substances Data: 110139-15-6(Hazardous Substances Data)

Usage

General Description

N-(8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide is a chemical compound with the molecular formula C14H15NO2. It is an acetamide derivative with a naphthalene ring and a substituent at the 1-position. N-(8-oxo-5,6,7,8-tetrahydronaphthalen-1-yl)acetamide has potential pharmaceutical applications, particularly in the field of medicinal chemistry and drug development. It may be studied for its potential biological activities and therapeutic properties due to its structural features and functional groups. Further research and investigations may be conducted to explore its potential pharmacological effects and medicinal uses.

Upstream product

• 210346-49-9 8-aminotetralone 
• 108-24-7 acetic anhydride 
• 6272-18-0 N-(5,6,7,8-tetrahydronaphthalen-1-yl)acetamide 
• 2217-41-6 1-amino-5,6,7,8-tetrahydronaphthalene 
• 58161-31-2 8-nitro-3,4-dihydro-1(2H)naphthalenone 
• 75-36-5 acetyl chloride 

Downstream Products

• 210346-49-9 8-aminotetralone 
• 628731-58-8 8-fluoro-3,4-dihydronaphthalene-1(2H)-one 
• 68449-32-1 8-chloro-1,2,3,4-tetrahydro-naphthalen-1-one 
• 651735-60-3 8-bromo-3,4-dihydronaphthalene-1(2H)-one 
• 651735-61-4 8-iodo-3,4-dihydronaphthalen-1(2H)-one 

Relevant articles and documents

Development of a new family of chiral auxiliaries

A new family of chiral auxiliaries designed on a conformationally restricted version of (-)-8-phenylmenthol has been developed. Both enantiomers are available from an inexpensive synthesis conducted on multigram scale. A first application has showed compa

5-HT2C RECEPTOR AGONISTS AND COMPOSITIONS AND METHODS OF USE

Provided in some embodiments are compounds of Formula A, as defined herein, that modulate the activity of 5-HT2C receptor. Also provided in some embodiments are methods, such as, for weight management, inducing satiety, and decreasing food intake, and for

CARBAMATE DERIVATIVE COMPOUNDS, PROCESSES FOR PREPARING THEM AND THEIR USES

The present invention relates to a pharmaceutical composition for treating or preventing CNS disorders containing a carbamate derivative compound and/or pharmaceutically acceptable salt thereof as an active ingredient. Furthermore, the present invention relates to a method for treatment or prevention CNS disorders comprising administering a carbamate derivative compound in a pharmaceutically effective amount to a subject in need of treatment or prevention of CNS disorders.